ArticleCancer communications (London, England)2019

Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.

Jun-Hai Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.